XML 28 R18.htm IDEA: XBRL DOCUMENT v3.5.0.2
STOCKHOLDERS' EQUITY (Notes)
 9 Months Ended
Sep. 30, 2016
STOCKHOLDERS' EQUITY
STOCKHOLDERS’ EQUITY

Stock-Based Compensation

Information with respect to option shares granted under all the Company’s stock incentive plans for the nine months ended September 30, 2016 was as follows:
 
Time-Based Shares
Performance-Based Shares
Total Shares
Weighted-
Average
Exercise
Price
Weighted-
Average
Remaining
Contractual
Term (years)
Aggregate
Intrinsic
Value
(in thousands)
Options outstanding as of January 1, 2016
4,345,334

—

4,345,334

$10.68
 
 
Exercised
(787,867
)
—

(787,867
)
$7.67
 
 
Forfeited or canceled
(655,602
)
—

(655,602
)
$15.28
 
 
Options outstanding as of September 30, 2016
2,901,865

—

2,901,865

$10.46
3.26
$600
Options vested as of September 30, 2016 or expected to vest
 
 
2,901,865

$10.46
3.25
$600
Options exercisable as of September 30, 2016
 
 
2,662,985

$10.72
3.14
$498


Information with respect to the Company’s non-vested restricted stock units for the nine months ended September 30, 2016 was as follows:
 
Non-Vested Restricted Stock Units
 
Time-Based Shares
Performance-Based Shares
Total Shares
Weighted-
Average
Grant-Date
Fair Value
Weighted-
Average
Remaining
Contractual
Term (years)
Aggregate
Intrinsic
Value
(in thousands)
Non-vested as of January 1, 2016
905,934

360,074

1,266,008

$9.97
 
 
Granted
916,972

489,482

1,406,454

$6.84
 
 
Vested
(397,936
)
—

(397,936
)
$11.95
 
 
Forfeited
(257,077
)
(155,719
)
(412,796
)
$7.93
 
 
Non-vested as of September 30, 2016
1,167,893

693,837

1,861,730

$7.64
0.86
$14,764
Expected to vest
 
 
1,589,999

$7.66
0.86
$12,609


Stock-based compensation was included in the following captions in the Company’s condensed consolidated statements of operations for the nine months ended September 30, 2016 and 2015 (in thousands):
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
2016
 
2015
 
2016
 
2015
Cost of products revenues
$
12

 
$
40

 
$
43

 
$
175

Cost of services revenues
145

 
142

 
445

 
476

Research and development expenses
73

 
73

 
222

 
225

Marketing and selling expenses
547

 
529

 
1,508

 
1,902

General and administrative expenses
951

 
1,603

 
3,898

 
4,953

 
$
1,728

 
$
2,387

 
$
6,116

 
$
7,731